4-{1-[4-(6-methoxy-naphthalen-2-yl)-phenyl]-2-methyl-propenyl}-pyridine | 1233693-21-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 4-{1-[4-(6-methoxy-naphthalen-2-yl)-phenyl]-2-methyl-propenyl}-pyridine
• 英文别名: 4-(1-(4-(6-methoxynaphthalen-2-yl)phenyl)-2-methylprop-1-enyl)pyridine；4-[1-[4-(6-Methoxynaphthalen-2-yl)phenyl]-2-methylprop-1-enyl]pyridine
• CAS: 1233693-21-4
• 化学式: C₂₆H₂₃NO
• 分子量: 365.475
• InChiKey: RWJYQUQBNISCOB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-{1-[4-(6-methoxy-naphthalen-2-yl)-phenyl]-2-methyl-propenyl}-pyridine 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 以0.18 g的产率得到6-(4-(2-Methyl-1-(pyridin-4-yl)prop-1-enyl)phenyl)naphthalen-2-ol
  参考文献：
  名称：

  Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors

  摘要：

  GYP 17 inhibition is a promising therapy for prostate cancer (PC) because proliferation of 80% of PC depends on androgen stimulation. Introduction of isopropylidene substituents onto the linker of biphenylmethylene 4-pyridines resulted in several strong GYP 17 inhibitors, which were more potent and selective, regarding GYP 11B1, 11B2, 19 and 3A4, than the drug candidate abiraterone.

  DOI：

  10.1021/jm100400a
• 作为产物：
  描述：

  4-(1-(4-bromophenyl)-2-methylprop-1-enyl)pyridine 、 6-甲氧基萘-2-硼酸 在 四丁基溴化铵 、 palladium diacetate 、 sodium carbonate 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 4.0h， 生成 4-{1-[4-(6-methoxy-naphthalen-2-yl)-phenyl]-2-methyl-propenyl}-pyridine
  参考文献：
  名称：

  Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors

  摘要：

  GYP 17 inhibition is a promising therapy for prostate cancer (PC) because proliferation of 80% of PC depends on androgen stimulation. Introduction of isopropylidene substituents onto the linker of biphenylmethylene 4-pyridines resulted in several strong GYP 17 inhibitors, which were more potent and selective, regarding GYP 11B1, 11B2, 19 and 3A4, than the drug candidate abiraterone.

  DOI：

  10.1021/jm100400a

文献信息

• Pd-Catalyzed Reaction of Sterically Hindered Hydrazones with Aryl Halides: Synthesis of Tetra-Substituted Olefins Related to <i>iso</i>-Combretastatin A4
  作者：Etienne Brachet、Abdallah Hamze、Jean-François Peyrat、Jean-Daniel Brion、Mouad Alami

  DOI：10.1021/ol101639g

  日期：2010.9.17

  PdCl2(MeCN)2 in combination with dppp proved to be a powerful and efficient catalyst for the coupling of sterically hindered N-arylsulfonylhydrazones with aryl halides, thus providing a flexible and convergent access to tetrasubstituted olefins related to iso-combretastatin A4 in good yields. This new protocol has been applied successfully to the formal synthesis of biphenylisopropylidene 4-pyridine

  PdCl 2（MeCN）2与dppp的结合被证明是一种强大而有效的催化剂，可用于将位阻N-芳基磺酰catalyst与芳基卤化物偶合，从而以高收率灵活，收敛地获得与异-combretastatin A4有关的四取代烯烃。该新方案已成功应用于生物学上感兴趣的联苯异亚丙基4-吡啶CYP17抑制剂12b的正式合成。
• Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors
  作者：Qingzhong Hu、Lina Yin、Carsten Jagusch、Ulrike E. Hille、Rolf W. Hartmann

  DOI：10.1021/jm100400a

  日期：2010.7.8

  GYP 17 inhibition is a promising therapy for prostate cancer (PC) because proliferation of 80% of PC depends on androgen stimulation. Introduction of isopropylidene substituents onto the linker of biphenylmethylene 4-pyridines resulted in several strong GYP 17 inhibitors, which were more potent and selective, regarding GYP 11B1, 11B2, 19 and 3A4, than the drug candidate abiraterone.